4534.T Stock - Mochida Pharmaceutical Co., Ltd.
Unlock GoAI Insights for 4534.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $105.16B | $102.89B | $103.26B | $110.18B | $103.00B |
| Gross Profit | $53.79B | $52.07B | $55.12B | $59.55B | $54.79B |
| Gross Margin | 51.1% | 50.6% | 53.4% | 54.1% | 53.2% |
| Operating Income | $8.13B | $5.80B | $8.51B | $14.39B | $12.00B |
| Net Income | $5.68B | $4.55B | $6.65B | $10.57B | $8.59B |
| Net Margin | 5.4% | 4.4% | 6.4% | 9.6% | 8.3% |
| EPS | $160.36 | $126.79 | $178.93 | $277.39 | $222.27 |
Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
4534.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | — | — | — | — |
Q4 2025 | Nov 4, 2025 | — | $55.35 | — | — |
Q3 2025 | Aug 1, 2025 | — | $53.43 | — | — |
Q2 2025 | May 12, 2025 | — | $2.26 | — | — |
Q1 2025 | Feb 3, 2025 | — | $78.42 | — | — |
Q4 2024 | Nov 1, 2024 | — | $35.85 | — | — |
Q3 2024 | Aug 2, 2024 | — | $43.83 | — | — |
Q2 2024 | May 13, 2024 | — | $2.90 | — | — |
Q1 2024 | Feb 5, 2024 | — | $45.17 | — | — |
Q4 2023 | Nov 2, 2023 | — | $32.02 | — | — |
Q3 2023 | Aug 4, 2023 | — | $46.23 | — | — |
Q2 2023 | May 15, 2023 | — | $-39.08 | — | — |
Q1 2023 | Feb 6, 2023 | — | $112.36 | — | — |
Q4 2022 | Nov 4, 2022 | — | $20.52 | — | — |
Q3 2022 | Aug 1, 2022 | — | $83.98 | — | — |
Q2 2022 | May 13, 2022 | — | $11.10 | — | — |
Q1 2022 | Feb 4, 2022 | — | $137.82 | — | — |
Q4 2021 | Nov 5, 2021 | — | $59.13 | — | — |
Q3 2021 | Jul 30, 2021 | — | $69.32 | — | — |
Latest News
Frequently Asked Questions about 4534.T
What is 4534.T's current stock price?
What is the analyst price target for 4534.T?
What sector is Mochida Pharmaceutical Co., Ltd. in?
What is 4534.T's market cap?
Does 4534.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 4534.T for comparison